The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.

The amyloid-cascade hypothesis posits that the role of amyloid β-peptide (Aβ) in Alzheimer disease (AD) involves polymerization into structures that eventually are deposited as amyloid plaques. During this process, neurotoxic oligomers are formed that induce synaptic loss and neuronal death. Several...

Full description

Bibliographic Details
Main Authors: Anna Sandebring, Hedvig Welander, Bengt Winblad, Caroline Graff, Lars O Tjernberg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3569467?pdf=render
_version_ 1811236550791397376
author Anna Sandebring
Hedvig Welander
Bengt Winblad
Caroline Graff
Lars O Tjernberg
author_facet Anna Sandebring
Hedvig Welander
Bengt Winblad
Caroline Graff
Lars O Tjernberg
author_sort Anna Sandebring
collection DOAJ
description The amyloid-cascade hypothesis posits that the role of amyloid β-peptide (Aβ) in Alzheimer disease (AD) involves polymerization into structures that eventually are deposited as amyloid plaques. During this process, neurotoxic oligomers are formed that induce synaptic loss and neuronal death. Several different isoforms of Aβ are produced, of which the 40 and 42 residue variants (Aβ40 and Aβ42) are the most common. Aβ42 has a strong tendency to form neurotoxic aggregates and is involved in AD pathogenesis. Longer Aβ isoforms, like the less studied Aβ43, are gaining attention for their higher propensity to aggregate into neurotoxic oligomers. To further investigate Aβ43 in AD, we conducted a quantitative study on Aβ43 levels in human brain. We homogenized human brain tissue and prepared fractions of various solubility; tris buffered saline (TBS), sodium dodecyl sulfate (SDS) and formic acid (FA). Levels of Aβ43, as well as Aβ40 and Aβ42, were quantified using ELISA. We compared quantitative data showing Aβ levels in occipital and frontal cortex from sporadic (SAD) and familial (FAD) AD cases, as well as non-demented (ND) controls. Results showed Aβ43 present in each fraction from the SAD and FAD cases, while its level was lower than the detection limit in the majority of the ND-cases. Aβ42 and Aβ43 were enriched in the less soluble fractions (SDS and FA) of SAD and FAD cases in both occipital and frontal cortex. Thus, although the total levels of Aβ43 in human brain are low compared to Aβ40 and Aβ42, we suggest that Aβ43 could initiate the formation of oligomers and amyloid plaques and thereby be crucial to AD pathogenesis.
first_indexed 2024-04-12T12:10:07Z
format Article
id doaj.art-6437bc5d52a94192bec3dab68b3fe0d6
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T12:10:07Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-6437bc5d52a94192bec3dab68b3fe0d62022-12-22T03:33:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0182e5584710.1371/journal.pone.0055847The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.Anna SandebringHedvig WelanderBengt WinbladCaroline GraffLars O TjernbergThe amyloid-cascade hypothesis posits that the role of amyloid β-peptide (Aβ) in Alzheimer disease (AD) involves polymerization into structures that eventually are deposited as amyloid plaques. During this process, neurotoxic oligomers are formed that induce synaptic loss and neuronal death. Several different isoforms of Aβ are produced, of which the 40 and 42 residue variants (Aβ40 and Aβ42) are the most common. Aβ42 has a strong tendency to form neurotoxic aggregates and is involved in AD pathogenesis. Longer Aβ isoforms, like the less studied Aβ43, are gaining attention for their higher propensity to aggregate into neurotoxic oligomers. To further investigate Aβ43 in AD, we conducted a quantitative study on Aβ43 levels in human brain. We homogenized human brain tissue and prepared fractions of various solubility; tris buffered saline (TBS), sodium dodecyl sulfate (SDS) and formic acid (FA). Levels of Aβ43, as well as Aβ40 and Aβ42, were quantified using ELISA. We compared quantitative data showing Aβ levels in occipital and frontal cortex from sporadic (SAD) and familial (FAD) AD cases, as well as non-demented (ND) controls. Results showed Aβ43 present in each fraction from the SAD and FAD cases, while its level was lower than the detection limit in the majority of the ND-cases. Aβ42 and Aβ43 were enriched in the less soluble fractions (SDS and FA) of SAD and FAD cases in both occipital and frontal cortex. Thus, although the total levels of Aβ43 in human brain are low compared to Aβ40 and Aβ42, we suggest that Aβ43 could initiate the formation of oligomers and amyloid plaques and thereby be crucial to AD pathogenesis.http://europepmc.org/articles/PMC3569467?pdf=render
spellingShingle Anna Sandebring
Hedvig Welander
Bengt Winblad
Caroline Graff
Lars O Tjernberg
The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.
PLoS ONE
title The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.
title_full The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.
title_fullStr The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.
title_full_unstemmed The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.
title_short The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.
title_sort pathogenic aβ43 is enriched in familial and sporadic alzheimer disease
url http://europepmc.org/articles/PMC3569467?pdf=render
work_keys_str_mv AT annasandebring thepathogenicab43isenrichedinfamilialandsporadicalzheimerdisease
AT hedvigwelander thepathogenicab43isenrichedinfamilialandsporadicalzheimerdisease
AT bengtwinblad thepathogenicab43isenrichedinfamilialandsporadicalzheimerdisease
AT carolinegraff thepathogenicab43isenrichedinfamilialandsporadicalzheimerdisease
AT larsotjernberg thepathogenicab43isenrichedinfamilialandsporadicalzheimerdisease
AT annasandebring pathogenicab43isenrichedinfamilialandsporadicalzheimerdisease
AT hedvigwelander pathogenicab43isenrichedinfamilialandsporadicalzheimerdisease
AT bengtwinblad pathogenicab43isenrichedinfamilialandsporadicalzheimerdisease
AT carolinegraff pathogenicab43isenrichedinfamilialandsporadicalzheimerdisease
AT larsotjernberg pathogenicab43isenrichedinfamilialandsporadicalzheimerdisease